Articles Referencing AEGR
Loss at Aegerion Narrower Than Expected - Analyst Blog
5/3/2013, 4:29 pm from Zacks.com in Investing, Business, Stocks
Aegerion Pharmaceuticals, Inc. ( AEGR ) reported first
quarter 2013 net loss per share of 64 cents, narrower than the
Zacks Consensus Estimate of a loss of 72 cents, but wider than... Read >>
Aegerion Incurs Wider Loss - Analyst Blog
3/7/2013, 1:14 pm from Zacks.com in Investing, Business, Stocks
Aegerion Pharmaceuticals, Inc. ( AEGR ) reported fourth
quarter 2012 net loss per share of 86 cents, wider than the Zacks
Consensus Estimate of a loss of 62 cents and the year-ago loss... Read >>
Pre-Market Earnings Report for March 6, 2013 : SPLS, BF/B, AEO, TFM, BIG, AEGR, HOV, WD, TRK, QRE, WILN, MFB
3/5/2013, 4:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings prior to
market open on 03/06/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Staples, Inc. ( SPLS ... Read >>
US Nod for ISIS/Sanofi's Kynamro - Analyst Blog
1/30/2013, 4:40 pm from Zacks.com in Investing, Business, Stocks
The US Food and Drug Administration (FDA) recently approved
Kynamro (mipomersen sodium) injection developed by Genzyme, a
Sanofi company ( SNY ) and
Isis Pharmaceuticals Inc. ( ISIS ).... Read >>
Aegerion Prices Stock Offering - Analyst Blog
1/14/2013, 4:32 pm from Zacks.com in Investing, Business, Stocks
Aegerion Pharmaceuticals, Inc. ( AEGR ) recently
provided more details on its public offering. The offering is
expected to close on Jan 16, 2013. The total offer consists of approximately... Read >>
Aegerion to Raise Funds - Analyst Blog
1/11/2013, 10:40 am from Zacks.com in Investing, Business, Stocks
Aegerion Pharmaceuticals, Inc. ( AEGR ) recently
announced its intention to raise funds through the issuance of its
common stock in an underwritten public offering. The funds raised through... Read >>
Aegerion Upbeat About 2013 - Analyst Blog
1/8/2013, 6:15 pm from Zacks.com in Investing, Business, Stocks
Aegerion Pharmaceuticals Inc. ( AEGR )
recently announced its 2013 guidance as the company prepares for
the launch of Juxtapid, which gained US Food and Drug
Administration (FDA) approval... Read >>
FDA Approves Aegerion's Juxtapid - Analyst Blog
12/26/2012, 5:21 pm from Zacks.com in Investing, Business, Stocks
The US Food and Drug Administration (FDA) recently approved
Aegerion Pharmaceuticals ' ( AEGR )
Juxtapid (lomitapide) capsules. Juxtapid has been approved for the
treatment of patients... Read >>
Wall Street Experts: Deutsche Bank Loves These Stocks Boosted by Insider Buying
1/9/2012, 10:57 pm from Kapitall in Investing, Investing Ideas, Stocks, US Markets
(Written by Rebecca Lipman, list compiled by Eben Esterhuizen, CFA . Short and EPS data from Yahoo! Finance) A sell side analyst produces detailed research that is circulated to... Read >>
Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most
12/16/2011, 5:38 pm from Kapitall in Investing, Investing Ideas, Stocks, US Markets
( Written by Rebecca Lipman. Institutional data sourced from Fidelity.) Covidien Plc ( COV ) plans to spin off its pharmaceuticals division from its surgical products in order to create a... Read >>
IPO Market: All eyes on the Groupon IPO
11/7/2011, 7:58 pm from Kapitall in Investing, Investing Ideas, Stocks, US Markets
( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA. Insider data sourced from Yahoo! Finance.) Can Groupon attract long-term investors? That’s the question currently on the... Read >>
IPO Stocks: Here's a List of IPO Stocks With Insider Buying
9/20/2011, 1:33 pm from Kapitall in Investing, Investing Ideas, Stocks
( Article by Becca Lipman. List compiled by Eben Esterhuizen, CFA. Data sourced from Yahoo! Finance.) Two-thirds of 2011's IPOs are below their initial offering price, leaving... Read >>